Tag: Eli Lilly

A wave of institutional investment and a strategic push to expedite a key drug approval are reinforcing the bullish narrative ...

Investor sentiment toward Eli Lilly turned cautious last week, with the pharmaceutical giant's stock declining approximately 4.5% over a five-day ...

Pharmaceutical titan Eli Lilly has delivered significant news on two distinct fronts, capturing investor attention. Beyond the intense spotlight on ...

Pharmaceutical titan Eli Lilly has launched an aggressive offensive in the lucrative weight-loss drug sector, initiating a price war that ...

The pharmaceutical titan Eli Lilly has escalated competition in the high-growth weight-loss medication sector with a bold pricing maneuver. By ...

The battle for dominance in the lucrative weight-loss drug sector is heating up. In a bold strategic move, Eli Lilly ...

Having recently surpassed the historic $1 trillion market capitalization milestone, pharmaceutical titan Eli Lilly now faces pressure on its share ...

Eli Lilly & Co. made corporate history by becoming the first pharmaceutical firm to surpass a $1 trillion market valuation. ...

Eli Lilly has become the first pharmaceutical company in history to achieve a market capitalization exceeding one trillion dollars. This ...

Eli Lilly has achieved a milestone previously reserved for technology behemoths, becoming the first pharmaceutical company to surpass a $1 ...